Vanda Pharmaceuticals Inc.
VNDA | NASDAQ
$5.16
+$0.03 (+0.58%)
At close: Sep 21, 2026, 4:00 PM ET
$5.15
-$0.01 (-0.19%)
Pre-market:
Sep 22, 2026, 7:33 AM ET
Market Data
Market Cap $310M
Enterprise Value $139.97M
Beta 0.65
Average Volume 968.35K
Shares Outstanding (Diluted) 60.23M
Shares Change YoY 2.09%
Institutional Ownership 77.74%
Exchange NASDAQ
ISIN US9216591084
Price Performance
Price Change 1M -3.4%
Price Change 3M -13.3%
Price Change 6M -28.8%
Price Change YTD -37.5%
Price Change 1Y 8.6%
Price Change 3Y 14.4%
Price Change 5Y -70.1%
1M CAGR (ann.) 3.2%
1Y CAGR (ann.) 14.2%
5Y CAGR (ann.) -20.9%
All-Time CAGR -4.4%
Valuation
PE Ratio -1.11
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.02
PS Ratio 1.44
Forward PS 0.90
PB Ratio 1.41
P/FCF Ratio -1.60
P/Adj. FCF Ratio -1.51
P/OCF Ratio -1.61
EV/Sales 0.65
EV/EBIT -0.78
EV/EBITDA -0.84
EV/FCF -0.72
Earnings Yield -89.7%
FCF Yield -62.4%
Adj. FCF Yield -66.2%
Financial Health
Net Cash $170.03M
Total Debt $0
Cash & Short-Term Investments $170.03M
Total Assets $412.47M
Current Ratio 1.61
Quick Ratio 1.60
Debt / Equity Ratio 0.10
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -1.37
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 92.8%
Operating Profit Margin -86.1%
EBITDA Margin -77.2%
Net Profit Margin -127.4%
FCF Margin -89.7%
Adj. FCF Margin -95.1%
SBC / Revenue 5.4%
SBC Impact (per share) -6.0%
Returns
Return on Assets -66.6%
Return on Equity -85.0%
Return on Invested Capital -73.4%
Return on Capital Employed -74.7%
Return on Tangible Assets -91.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -3.3%
Revenue CAGR 5Y -3.6%
Revenue CAGR 10Y 5.2%
EPS CAGR 3Y -111.7%
EPS CAGR 5Y -100.5%
EPS CAGR 10Y -136.1%
FCF CAGR 3Y -106.4%
FCF CAGR 5Y -162.9%
FCF CAGR 10Y -246.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 19
EPS Growth Next 3Y 33.2%
Revenue Growth Next 3Y 29.3%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.72
EPS Growth Est (next Q) 89.5%
Revenue Est (next Q) $69.3M
Revenue Growth Est (next Q) 23.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $21
Price Target Upside 307.0%
Cash Flow
Operating Cash Flow $-192.55M
Free Cash Flow $-193.44M
Adj. Free Cash Flow $-205.07M
FCF Per Share -$3.21
OCF Per Share -$3.20
OCF/S Ratio -89.3%
Income Statement
Revenue $215.72M
Gross Profit $200.23M
Operating Income $-185.67M
EBITDA $-166.62M
Net Income $-274.85M
EPS (Diluted) -$4.63
Revenue / Employee $404.73K
Profit / Employee $-515.67K
Employees 533
Add to Watchlist
Select watchlists to add or remove VNDA